News Chart VBI Vaccines Inc. Toronto S.E.

Equities

VBV

CA91822J1030

Delayed Toronto S.E. Other stock markets 03:09:59 24/03/2018 am IST			5-day change	1st Jan Change
4.82 ^CAD	-5.12%		-7.66%	-10.58%

29/05	VBI Vaccines Inc. Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients	CI
22/05	VBI Vaccines Inc. Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients	CI

400378df9b8a82e9e5.MewR-TUR3f1vXP78ZJnycOB72oU79xUyQeO1zLa2JxY.cr5_ik9zgrQtBci0UKm2FtdOnOdtkyFHNLH7p-zmE1FTilORAyGQlCEWiQ~f9fa5f18781d12b27b910f2818b2d31c